These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 12590709

  • 1. Acute promyelocytic leukemia M3: cytomorphologic, immunophenotypic, cytogenetic, and molecular variants.
    Sucić M, Zadro R, Burazer B, Labar B, Nemet D, Mrsić M, Aurer I, Mrsić S, Hitrec V, Boban D, Marković-Glamocak M, Batinić D, Uzarević B, Stavljenić-Rukavina A.
    J Hematother Stem Cell Res; 2002 Dec; 11(6):941-50. PubMed ID: 12590709
    [Abstract] [Full Text] [Related]

  • 2. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
    Rizzatti EG, Portieres FL, Martins SL, Rego EM, Zago MA, Falcão RP.
    Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
    [Abstract] [Full Text] [Related]

  • 3. [Detection of PML/RARalpha gene transcripts in 46 newly diagnosed acute promyelocytic leukemia patients by real-time quantitative reverse-transcription polymerase chain reaction].
    Zhu HH, Liu YR, Qin YZ, Li JL, Chang Y, Wang YZ, Shan FX, Jiang B, Lu DP.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):1-5. PubMed ID: 17490509
    [Abstract] [Full Text] [Related]

  • 4. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis.
    Lin P, Hao S, Medeiros LJ, Estey EH, Pierce SA, Wang X, Glassman AB, Bueso-Ramos C, Huh YO.
    Am J Clin Pathol; 2004 Mar; 121(3):402-7. PubMed ID: 15023045
    [Abstract] [Full Text] [Related]

  • 5. CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint.
    Biondi A, Luciano A, Bassan R, Mininni D, Specchia G, Lanzi E, Castagna S, Cantù-Rajnoldi A, Liso V, Masera G.
    Leukemia; 1995 Sep; 9(9):1461-6. PubMed ID: 7658712
    [Abstract] [Full Text] [Related]

  • 6. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
    Paietta E, Goloubeva O, Neuberg D, Bennett JM, Gallagher R, Racevskis J, Dewald G, Wiernik PH, Tallman MS, Eastern Cooperative Oncology Group.
    Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165
    [Abstract] [Full Text] [Related]

  • 7. CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform.
    Foley R, Soamboonsrup P, Carter RF, Benger A, Meyer R, Walker I, Wan Y, Patterson W, Orzel A, Sunisloe L, Leber B, Neame PB.
    Am J Hematol; 2001 May; 67(1):34-41. PubMed ID: 11279655
    [Abstract] [Full Text] [Related]

  • 8. Molecular analysis of the PML/RAR alpha chimeric gene in pediatric acute promyelocytic leukemia.
    Kane JR, Head DR, Balazs L, Hulshof MG, Motroni TA, Raimondi SC, Carroll AJ, Behm FG, Krance RA, Shurtleff SA, Downing JR.
    Leukemia; 1996 Aug; 10(8):1296-302. PubMed ID: 8709634
    [Abstract] [Full Text] [Related]

  • 9. Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases.
    Guglielmi C, Martelli MP, Diverio D, Fenu S, Vegna ML, Cantù-Rajnoldi A, Biondi A, Cocito MG, Del Vecchio L, Tabilio A, Avvisati G, Basso G, Lo Coco F.
    Br J Haematol; 1998 Sep; 102(4):1035-41. PubMed ID: 9734655
    [Abstract] [Full Text] [Related]

  • 10. Rapid diagnostic approach to PML-RARalpha-positive acute promyelocytic leukemia.
    Schoch C, Schnittger S, Kern W, Lengfelder E, Löffler H, Hiddemann W, Haferlach T.
    Hematol J; 2002 Sep; 3(5):259-63. PubMed ID: 12391544
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells.
    Benedetti L, Levin AA, Scicchitano BM, Grignani F, Allenby G, Diverio D, Lo Coco F, Avvisati G, Ruthardt M, Adamo S, Pelicci PG, Nervi C.
    Blood; 1997 Aug 01; 90(3):1175-85. PubMed ID: 9242550
    [Abstract] [Full Text] [Related]

  • 12. PML/RAR alpha(+) hypergranular acute promyelocytic leukemia (M3) developing into an M3 acute myelocytic leukemia without PML/RAR alpha.
    Ruiz-Argüelles GJ, Ruiz-Delgado GJ, Reyes-Núñez V.
    Acta Haematol; 2000 Aug 01; 104(2-3):124-7. PubMed ID: 11154988
    [Abstract] [Full Text] [Related]

  • 13. Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level.
    Martinelli G, Ottaviani E, Visani G, Testoni N, Montefusco V, Tura S.
    Haematologica; 1998 Sep 01; 83(9):860-3. PubMed ID: 9825588
    [Abstract] [Full Text] [Related]

  • 14. Rapid diagnosis of acute promyelocytic leukemia by analyzing the immunocytochemical pattern of the PML protein with the monoclonal antibody PG-M3.
    Villamor N, Costa D, Aymerich M, Esteve J, Carrió A, Rozman M, Aguilar JL, Falini B, Montserrat E, Campo E, Colomer D.
    Am J Clin Pathol; 2000 Nov 01; 114(5):786-92. PubMed ID: 11068554
    [Abstract] [Full Text] [Related]

  • 15. Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML).
    Falini B, Flenghi L, Fagioli M, Lo Coco F, Cordone I, Diverio D, Pasqualucci L, Biondi A, Riganelli D, Orleth A, Liso A, Martelli MF, Pelicci PG, Pileri S.
    Blood; 1997 Nov 15; 90(10):4046-53. PubMed ID: 9354674
    [Abstract] [Full Text] [Related]

  • 16. The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements.
    Orfao A, Chillón MC, Bortoluci AM, López-Berges MC, García-Sanz R, Gonzalez M, Tabernero MD, García-Marcos MA, Rasillo AI, Hernández-Rivas J, San Miguel JF.
    Haematologica; 1999 May 15; 84(5):405-12. PubMed ID: 10329918
    [Abstract] [Full Text] [Related]

  • 17. Acute myeloblastic leukaemias of FAB types M6 and M4, with cryptic PML/RARalpha fusion gene formation, relapsing as acute promyelocytic leukaemia M3.
    Virchis A, Massey E, Butler T, Devaraj P, Wright F, Secker-Walker L, Prentice HG, Mehta A.
    Br J Haematol; 2001 Sep 15; 114(3):551-6. PubMed ID: 11552979
    [Abstract] [Full Text] [Related]

  • 18. Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
    Slack JL, Arthur DC, Lawrence D, Mrózek K, Mayer RJ, Davey FR, Tantravahi R, Pettenati MJ, Bigner S, Carroll AJ, Rao KW, Schiffer CA, Bloomfield CD.
    J Clin Oncol; 1997 May 15; 15(5):1786-95. PubMed ID: 9164186
    [Abstract] [Full Text] [Related]

  • 19. Development and validation of a droplet digital PCR assay for the evaluation of PML-RARα fusion transcripts in acute promyelocytic leukemia.
    Jiang XW, Chen SZ, Zhu XY, Xu XX, Liu Y.
    Mol Cell Probes; 2020 Oct 15; 53():101617. PubMed ID: 32585184
    [Abstract] [Full Text] [Related]

  • 20. Acute promyelocytic leukemia with a STAT5b-RARα fusion transcript defined by array-CGH, FISH, and RT-PCR.
    Chen H, Pan J, Yao L, Wu L, Zhu J, Wang W, Liu C, Han Q, Du G, Cen J, Xue Y, Wu D, Sun M, Chen S.
    Cancer Genet; 2012 Jun 15; 205(6):327-31. PubMed ID: 22749039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.